Plasma membrane coenzyme Q: evidence for a role in autism

Frederick L Crane,1 Hans Löw,2 Iris Sun,1 Placido Navas,3 Anna Gvozdjáková41Department of Biological Sciences, Purdue University, West Lafayette, IN, USA; 2Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden; 3Centro Andaluz de Biologí...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Crane FL, Löw H, Sun I, Navas P, Gvozdjáková A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/d72e4adb59264f4fa956c9bd5cad846e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d72e4adb59264f4fa956c9bd5cad846e
record_format dspace
spelling oai:doaj.org-article:d72e4adb59264f4fa956c9bd5cad846e2021-12-02T08:44:21ZPlasma membrane coenzyme Q: evidence for a role in autism1177-5475https://doaj.org/article/d72e4adb59264f4fa956c9bd5cad846e2014-05-01T00:00:00Zhttp://www.dovepress.com/plasma-membrane-coenzyme-q-evidence-for-a-role-in-autism-a17046https://doaj.org/toc/1177-5475 Frederick L Crane,1 Hans Löw,2 Iris Sun,1 Placido Navas,3 Anna Gvozdjáková41Department of Biological Sciences, Purdue University, West Lafayette, IN, USA; 2Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden; 3Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide, Sevilla, Spain; 4Pharmacobiochemical Laboratory of Third Medical Department, Medical Faculty, Comenius University in Bratislava, Bratislava, SlovakiaBackground: The Voltage Dependent Anion Channel (VDAC) is involved in control of autism. Treatments, including coenzyme Q, have had some success on autism control.Data sources: Correlation of porin redox activity and expression of autism is based on extensive literature, especially studies of antibodies, identification of cytosolic nicotinamide adenine dinucleotide reduced (NADH) dehydrogenase activity in the VDAC, and evidence for extreme sensitivity of the dehydrogenase to a mercurial. Evidence for a coenzyme Q requirement came from extraction and analog inhibition of NADH ferricyanide reductase in the erythrocyte plasma membrane, done in 1994, and reinterpreted when it was identified in VDAC in 2004. The effects of ubiquinol (the QH2 – reduced form of coenzyme Q) in children with autism were studied.Results: A new role for coenzyme Q in the porin channels has implications on autism. Ubiquinol, the more active form of coenzyme Q, produces favorable response in children with autism. Agents which affected electron transport in porin show parallel effects in autism.Conclusion: We propose a hypothesis that autism is controlled by a coenzyme Q-dependent redox system in the porin channels; this conclusion is based on the effects of agents that positively or negatively affect electron transport and the symptoms of autism. The full understanding of the mechanism of their control needs to be established.Keywords: porin, channel, oxidation, reduction, autismCrane FLLöw HSun INavas PGvozdjáková ADove Medical PressarticleMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol 2014, Iss default, Pp 199-205 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Crane FL
Löw H
Sun I
Navas P
Gvozdjáková A
Plasma membrane coenzyme Q: evidence for a role in autism
description Frederick L Crane,1 Hans Löw,2 Iris Sun,1 Placido Navas,3 Anna Gvozdjáková41Department of Biological Sciences, Purdue University, West Lafayette, IN, USA; 2Department of Molecular Medicine, Karolinska Institute, Stockholm, Sweden; 3Centro Andaluz de Biología del Desarrollo, Universidad Pablo de Olavide, Sevilla, Spain; 4Pharmacobiochemical Laboratory of Third Medical Department, Medical Faculty, Comenius University in Bratislava, Bratislava, SlovakiaBackground: The Voltage Dependent Anion Channel (VDAC) is involved in control of autism. Treatments, including coenzyme Q, have had some success on autism control.Data sources: Correlation of porin redox activity and expression of autism is based on extensive literature, especially studies of antibodies, identification of cytosolic nicotinamide adenine dinucleotide reduced (NADH) dehydrogenase activity in the VDAC, and evidence for extreme sensitivity of the dehydrogenase to a mercurial. Evidence for a coenzyme Q requirement came from extraction and analog inhibition of NADH ferricyanide reductase in the erythrocyte plasma membrane, done in 1994, and reinterpreted when it was identified in VDAC in 2004. The effects of ubiquinol (the QH2 – reduced form of coenzyme Q) in children with autism were studied.Results: A new role for coenzyme Q in the porin channels has implications on autism. Ubiquinol, the more active form of coenzyme Q, produces favorable response in children with autism. Agents which affected electron transport in porin show parallel effects in autism.Conclusion: We propose a hypothesis that autism is controlled by a coenzyme Q-dependent redox system in the porin channels; this conclusion is based on the effects of agents that positively or negatively affect electron transport and the symptoms of autism. The full understanding of the mechanism of their control needs to be established.Keywords: porin, channel, oxidation, reduction, autism
format article
author Crane FL
Löw H
Sun I
Navas P
Gvozdjáková A
author_facet Crane FL
Löw H
Sun I
Navas P
Gvozdjáková A
author_sort Crane FL
title Plasma membrane coenzyme Q: evidence for a role in autism
title_short Plasma membrane coenzyme Q: evidence for a role in autism
title_full Plasma membrane coenzyme Q: evidence for a role in autism
title_fullStr Plasma membrane coenzyme Q: evidence for a role in autism
title_full_unstemmed Plasma membrane coenzyme Q: evidence for a role in autism
title_sort plasma membrane coenzyme q: evidence for a role in autism
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/d72e4adb59264f4fa956c9bd5cad846e
work_keys_str_mv AT cranefl plasmamembranecoenzymeqevidenceforaroleinautism
AT loumlwh plasmamembranecoenzymeqevidenceforaroleinautism
AT suni plasmamembranecoenzymeqevidenceforaroleinautism
AT navasp plasmamembranecoenzymeqevidenceforaroleinautism
AT gvozdjaacutekovaacutea plasmamembranecoenzymeqevidenceforaroleinautism
_version_ 1718398436470947840